Danaher Pays Down Facility Borrowings Tied to Beckman Buy | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Danaher disclosed after the close of the market yesterday that it has reduced its commitments under a $3 billion unsecured revolving credit facility to zero and has terminated the facility, effective as of Dec. 29, 2011.

The Washington, DC-based conglomerate had inked the credit facility in June to help pay for its $6.8 billion acquisition of Beckman Coulter.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.